Novel compound heterozygous LIAS mutations cause glycine encephalopathy

15Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Glycine encephalopathy (GCE) is a rare autosomal recessive disorder caused by defects in the glycine cleavage complex. Here we report a patient with GCE and elevated level of glycine in both the serum and the cerebrospinal fluid. Trio-based whole-exome sequencing identified novel compound heterozygous mutations (c.738-2A>G and c.929T>C (p.Met310Thr)) in LIAS. To date, three homozygous mutations have been reported in LIAS. All previously reported GCE patients also show elevated level of serum glycine. Our data further supports LIAS mutations as a genetic cause for GCE.

Cite

CITATION STYLE

APA

Tsurusaki, Y., Tanaka, R., Shimada, S., Shimojima, K., Shiina, M., Nakashima, M., … Matsumoto, N. (2015). Novel compound heterozygous LIAS mutations cause glycine encephalopathy. Journal of Human Genetics, 60(10), 631–635. https://doi.org/10.1038/jhg.2015.72

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free